上海莼试生物技术有限公司
   
菜单 Close 公司首页 公司介绍 公司动态 产品展厅 证书荣誉 联系方式 在线留言
您当前的位置: 网站首页 > 产品展厅 >抗体 >磷酸化过氧化酶活化增生受体γ抗体说明书
产品展厅
磷酸化过氧化酶活化增生受体γ抗体说明书
  • 品牌:上海莼试
  • 产地:进口、国产
  • 货号:CS10600
  • 发布日期: 2018-12-29
  • 更新日期: 2025-11-10
产品详请
产地 进口、国产
品牌 上海莼试
保存条件 Store at -20 °C
货号 CS10600
应用范围 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
CAS编号
抗体名 Anti-Phospho-PPAR Gamma (ser112)
克隆性
靶点 详见说明书
适应物种 详见说明书
形态 详见说明书
宿主 详见说明书
亚型 IgG
标识物 详见说明书
浓度 1mg/1ml%
免疫原 KLH conjugated synthesised phosphopeptide derived from human PPAR Gamma around the phosphorylation site of ser112

磷酸化过氧化酶活化增生受体γ抗体说明书 英文名称  Anti-Phospho-PPAR Gamma (ser112)

中文名称  磷酸化过氧化酶活化增生受体γ抗体说明书 

     CIMT1; HUMPPARG; NR1C3; Nuclear receptor subfamily 1 group C member 3; PAX8/PPARG Fusion Gene; Peroxisome Proliferator Activated Receptor gamma; PPAR gamma; PPARG; PPARG1; PPARG2; PPARG3l; PPARG_HUMAN.

产品属性:

      1mg/1ml

  0.1ml/100μg

抗体来源  Rabbit

克隆类型   polyclonal

交叉反应   Human, Mouse, Rat, Dog, Pig, Rabbit, Guinea Pig

产品类型   一抗 磷酸化抗体  

研究领域     免疫学 细胞凋亡 激酶和磷酸酶

蛋白分子量  predicted molecular weight: 57kDa 

       Lyophilized or Liquid

  KLH conjugated synthesised phosphopeptide derived from human PPAR Gamma around the phosphorylation site of ser112

      IgG

纯化方法   affinity purified by Protein A

   0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide

磷酸化过氧化酶活化增生受体γ抗体说明书 产品应用   WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500

(石蜡切片需做抗原修复) 

 not yet tested in other applications.

 optimal dilutions/concentrations should be determined by the end user.  

保存条件  Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. 

Important Note  This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. 

产品介绍 This gene encodes a member of the peroxisome proliferator-activated receptor (PPAR) subfamily of nuclear receptors. PPARs form heterodimers with retinoid X receptors (RXRs) and these heterodimers regulate transcription of various genes. Three subtypes of PPARs are known: PPAR-alpha, PPAR-delta, and PPAR-gamma. The protein encoded by this gene is PPAR-gamma and is a regulator of adipocyte differentiation. Additionally, PPAR-gamma has been implicated in the pathology of numerous diseases including obesity, diabetes, atherosclerosis and cancer. Alternatively spliced transcript variants that encode different isoforms have been described. [provided by RefSeq, Jul 2008].

Function : Receptor that binds peroxisome proliferators such as hypolipidemic drugs and fatty acids. Once activated by a ligand, the receptor binds to a promoter element in the gene for acyl-CoA oxidase and activates its transcription. It therefore controls the peroxisomal beta-oxidation pathway of fatty acids. Key regulator of adipocyte differentiation and glucose homeostasis.

Subunit : "Forms a heterodimer with the retinoic acid receptor RXRA called adipocyte-specific transcription factor ARF6. Interacts with NCOA6 coactivator, leading to a strong increase in transcription of target genes. Interacts with coactivator PPARBP, leading to a mild increase in transcription of target genes. Interacts with FAM120B. Interacts with PRDM16 (By similarity). Interacts with NOCA7 in a ligand-inducible manner. Interacts with NCOA1 LXXLL motifs. Interacts with DNTTIP2, MAP2K1/MEK1, PRMT2 and TGFB1I1. Interacts with PDPK1. Interacts with ASXL1 AND ASXL2.

Subcellular Location : Nucleus. Cytoplasm.

DISEASE : Note=Defects in PPARG can lead to type 2 insulin-resistant diabetes and hyptertension. PPARG mutations may be associated with colon cancer.

Defects in PPARG may be associated with susceptibility to obesity (OBESITY) [MIM:601665]. It is a condition characterized by an increase of body weight beyond the limitation of skeletal and physical requirements, as the result of excessive accumulation of body fat.

Defects in PPARG are the cause of familial partial lipodystrophy type 3 (FPLD3) [MIM:604367]. Familial partial lipodystrophies (FPLD) are a heterogeneous group of genetic disorders characterized by marked loss of subcutaneous (sc) fat from the extremities. Affected individuals show an increased preponderance of insulin resistance, diabetes mellitus and dyslipidemia.

Genetic variations in PPARG can be associated with susceptibility to glioma type 1 (GLM1) [MIM:137800]. Gliomas are central nervous system neoplasms derived from glial cells and comprise astrocytomas, glioblastoma multiforme, oligodendrogliomas, and ependymomas. Note=Polymorphic PPARG alleles have been found to be significantly over-represented among a cohort of American patients with sporadic glioblastoma multiforme suggesting a possible contribution to disease susceptibility.

Similarity : Belongs to the nuclear hormone receptor family. NR1 subfamily.

Contains 1 nuclear receptor DNA-binding domain.

Database links : UniProtKB/Swiss-Prot: P37231.3

类固醇受体(Steroid Receptors)

过氧化物酶体增殖物激活受体γ(PPARγ)主要存在于白色脂肪组织,PPARγ对于脂肪生成、稳定、反应、和等的发生都起到重要的作用。主要在脂肪细胞内表达。PPARγ是噻唑烷二酮类药物(TZDs)作用的药靶,又是脂肪细胞分化的重要调节因子。经研究发现,PPARγ在及抵抗的机制中具有十分重要的意义,是的重要药靶。

过氧化物酶体增殖物激活受体γ(PPARγ)属Ⅱ型核受体超家族成员,主要在脂肪细胞内表达。PPARγ是噻唑烷二酮类药物(TZDs)作用的药靶,又是脂肪细胞分化的重要调节因子。现有研究(包括一次于美国加州大学进行的研究)发现PPARγ在及抵抗的机制中具有十分重要的意义,是的重要药靶。目前,该受体蛋白质水平的筛选模式已经建立,并正在建立该受体的报告基因的细胞水平筛选评价模式。

实验流程:

全、新、优、品、好四大特点:

磷酸化过氧化酶活化增生受体γ抗体说明书 全:公司提供上万种产品,涵盖了生物试剂,elisa试剂盒,标准品,培养基,原装耗材,抗体、培养基、ATCC细胞等,基本上各种科研所需产品在我司都能找到。

新:产品更新速度较快,基本上每周都有新产品出现。

优:产品质量好,投诉比较少。

好:我公司具有优质的技术团队,产品一旦售出,实验过程中遇到困难可提供在线技术咨询。使您使用产品时没有任何的后顾之忧。

正在热销的相关产品:

Anti-cofilin/FITC 荧光素标记兔抗人、大、小鼠丝切蛋白抗体IgGMulti-class antibodies规格: 0.2ml

Anti-ISR- Alpha protein/FITC 荧光素标记受体-α蛋白抗体IgGMulti-class antibodies规格: 0.2ml

Rhesus antibody Rh CCDC88B/BRLZ/HkRP3 大脑亮氨酸拉链结构域蛋白抗体 规格 0.2ml

HSTF2/HSF2 peptide 热休克转录因子2抗原 0.5mg

HSD17B2 英文名称: 羟类固醇脱氢酶17β2抗体 0.1ml

Rhesus antibody Rh SOD3 超氧化物歧化酶3抗体 规格 0.2ml

Anti-ISR- Alpha protein/FITC 荧光素标记受体-α蛋白抗体IgGMulti-class antibodies规格: 0.2ml

ECP ELISA Kit 大鼠嗜酸性粒细胞阳离子蛋白Multi-class antibodies规格: 48T

Anti-Phospho-TCTP (Ser46) 磷酸化翻译控制蛋白抗体Multi-class antibodies规格: 0.1ml

Rhesus antibody Rh Goat Anti-Bovine IgG/HRP 辣根过氧化物酶标记的羊抗IgG 规格 0.1ml

DA ELISA Kit 大鼠多巴胺 96T

Phospho-NFKB1 (Ser927) 英文名称: 磷酸化细胞核因子p50/k基因结合核因子抗体 0.1ml

BLAME 英文名称: BLAME抗体 0.1ml

Anti-Phospho-TCTP (Ser46) 磷酸化翻译控制蛋白抗体Multi-class antibodies规格: 0.1ml

H2-K1(Human Histocompatibility 2-K1-K region) ELISA Kit 人组织相容性2-K1-K 区Multi-class antibodies规格: 48T

Anti-PAX5 配对盒基因5抗体Multi-class antibodies规格: 0.2ml

Rhesus antibody Rh HOMER3 HOMER3蛋白抗体 规格 0.2ml

Human anti-cartilage-antibody ELISA Kit 人抗软骨抗体 96T

phospho-PI3-kinase regulatory subunit gamma (Tyr199) 英文名称: 磷酸化磷脂酰肌醇激酶调节亚单位gamma抗体 0.1ml

Cullin 3 英文名称: Cullin3抗体 0.2ml

Anti-PAX5 配对盒基因5抗体Multi-class antibodies规格: 0.2ml

CL-0326Caki-2(人肾透明细胞癌细胞)5×106cells/瓶×2

CD36 Others Cynomolgus 食蟹猴 CD36 / SCARB3 人细胞裂解液 (阳性对照)

人真皮成纤维细胞-新生儿总RNAHDF-n NA

MDA-MB-435细胞,人癌高转移细胞 鼠癌细胞系,MA-782细胞 原代滑膜皮细胞特制基础无血清培养基Many types of cells包装:500/100ml

PATU8988(人*癌细胞) 5×106cells/瓶×2

HDLEC adult Pellet 人类皮肤淋巴管内皮细胞团块(成年捐献者) > 1 mio.cells 角质细胞生长添加物(不含BPE)KGS-2

CL-0324BT-20(人癌细胞)5×106cells/瓶×2

ROR1 Others Human 人 ROR1 人细胞裂解液 (阳性对照)

人表皮黑色素细胞-深色素总RNAHEM-d NA

盘羊皮肤细胞;ASHS2 中国仓鼠二氢叶酸还原酶缺陷细胞,CHO/dhFr-细胞 Ca763细胞,615小鼠株

转化细胞

HA Others H5N1 甲型 H5N1 (A/Egypt/N05056/2009) 血凝素HA1 (Hemagglutinin) 人细胞裂解液 (阳性对照)

磷酸化过氧化酶活化增生受体γ抗体说明书 TMED1 Others Human 人 TMED1 人细胞裂解液 (阳性对照)

人细胞;Hela S3 [HeLaS3]

人肝实质细胞完全培养基 100mL

L6565细胞,小鼠克隆细胞系 破杆菌/梭菌Closidium tetani 猴脉络膜-视网膜(内皮)细胞;RF/6A

CXCL12 Protein Human 重组人 CXCL12 / SDF-1 蛋白 (isoform a, His 标签)

PIEC(猪髋动脉内皮细胞 ) 5×106cells/瓶×2 食蟹猴 CD10 / Neprilysin / MME 人细胞裂解液 (阳性对照)

技术外包服务:

磷酸化过氧化酶活化增生受体γ抗体说明书 分子生物学:质粒抽提、PCRQ-PCRRT-PCR、分子生物学:基因合成、引物合成、基因测序、载体构建等

蛋白工程:原核、哺乳动物蛋白表达系统等

病毒包装:腺病毒、慢病毒等

抗体工程:磁珠分选、病理染色、WBELISAIPIFIHCFACSConfocal等等

细胞工程:细胞表型分析(凋亡、增殖、周期、迁移、侵袭、修复、克隆形成)、细胞培养、细胞膜制备、稳定细胞株构建、细胞RNAi技术等等。


联系方式
手机:13585831301
Q Q: